Treatment for superficial infusion thrombophlebitis of the upper extremity

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 3, 2014, Pages

  Di Nisio, Marcello ^a,b   Peinemann, Frank ^c   Porreca, Ettore ^a   Rutjes, Anne W S ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ALLERGIC REACTION; ARM PAIN; ARTICLE; BLEEDING; BLOODSTREAM INFECTION; CATHETER REMOVAL; CRYOTHERAPY; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SUPERFICIAL THROMBOPHLEBITIS; SYSTEMATIC REVIEW; THERMOTHERAPY; UPPER LIMB; VENOUS THROMBOEMBOLISM;

EID: 85041793805     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011015     Document Type: Article

References (36)

1. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary?. Archives of Internal Medicine 1998;158(2):151-6.
2. Collin J, Collin C, Constable FL, Johnston ID. Infusion thrombophlebitis and infection with various cannulas. Lancet 1975;2(7926):150-3.
3. de la Sierra A, Cardellach F, Cobo E, Bové A, Roigé M, Santos MJ, et al.Iatrogenic illness in a department of general internal medicine: a prospective study. Mount Sinai Journal of Medicine 1989;56(4):267-71.
4. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD004982.pub5].
5. Everitt NJ, Krupowicz DW, Evans JA, McMahon MJ. Ultrasonographic investigation of the pathogenesis of infusion thrombophlebitis. British Journal of Surgery 1997;84(5):642-5.
6. Fonkalsrud EW, Carpenter K, Masuda JY, Beckerman JH. Prophylaxis against postinfusion phlebitis. Surgery, Gynecology and Obstetrics 1971;133(2):253-6.
7. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care 1988;16(3):265-71.
8. Brozek J, Oxman A, Schünemann H. GRADEprofiler (GRADEpro). 3.2 for Windows. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, 2008.
9. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
10. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in medicine 2006;25(20):3443-57.
11. Hershey CO, Tomford JW, McLaren CE, Porter DK, Cohen DI. The natural history of intravenous catheter associated phlebitis. Archives of Internal Medicine 1984;144(7):1373-5.
12. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
13. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):454S-545S.
14. Lee WL, Chen HL, Tsai TY, Lai IC, Chang WC, Huang CH, et al.Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. American Journal of Infection Control 2009;37(8):683-6.
15. Maki D, Goldman DA, Rhame FS. Infection control in intravenous therapy. Annals of Internal Medicine 1973;79(6):867-87.
16. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987;258(17):2396-403.
17. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Annals of Internal Medicine 1991;114(10):845-54.
18. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006;81(9):1159-71.
19. Monreal M, Quilez F, Rey-Joly C, Rodriguez S, Sopena N, Neira C, et al.Infusion phlebitis in patients with acute pneumonia. a prospective study. Chest 1999;115(6):1576-80.
20. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ 1998;316(7136):969-75.
21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
22. Rutjes AW, Nüesch E, Sterchi R, Kalichman L, Hendriks E, Osiri M, et al.Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD002823.pub2].
23. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Smith I, Hathaway M, Goldman C, Ng J, Brunton J, Simor AE, et al.A randomized study to determine complications associated with the duration of heparin locks. Research in Nursing Health 1990;13(6):367-73.
25. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team. a randomized controlled trial. Archives of Internal Medicine 1998;158(5):473-7.
26. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. Chichester, UK: John Wiley & Sons, 2004.
27. Stata Corp LP College Station. Stata. 12.1. Texas, USA: Stata Corp LP College Station, 2012.
28. Stein JM, Pruitt BA Jr. Suppurative thrombophlebitis. A lethal iatrogenic disease. New England Journal of Medicine 1970;282(26):1452-5.
29. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55.
30. Stratton CW. Infection related to intravenous infusions. Heart & Lung 1982;11(2):123-37.
31. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. American Journal of Medicine 2002;113(2):146-51.
32. Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E, et al.The Rhode Island Nosocomial Infection Consortium. An epidemiologic study of the risks associated with peripheral intravenous catheters. American Journal of Epidemiology 1983;118(6):839-51.
33. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Statistics in Medicine 1999;18(20):2693-708.
34. Timmer JG, Schipper HG. Peripheral venous nutrition: the equal relevance of volume load and osmolarity in relation to phlebitis. Clinical Nutrition 1991;10(2):71-5.
35. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. Archives of Internal Medicine 1984;144(6):1191-4.
36. Webster J, Osborne S, Rickard CM, New K. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD007798.pub3].